[Localized MSI/dMMR gastric cancer patients, perioperative immunotherapy instead of chemotherapy: The GERCOR NEONIPIGA phase II study is opened to recruitment]. [electronic resource]
Producer: 20200506Description: 438-446 p. digitalISSN:- 1769-6917
- Adenocarcinoma -- drug therapy
- Antineoplastic Agents, Immunological -- therapeutic use
- Chemotherapy, Adjuvant
- Clinical Trials, Phase II as Topic
- DNA Mismatch Repair
- Disease-Free Survival
- Humans
- Ipilimumab -- therapeutic use
- Microsatellite Instability
- Multicenter Studies as Topic
- Neoadjuvant Therapy -- methods
- Nivolumab -- therapeutic use
- Patient Selection
- Perioperative Care
- Phenotype
- Stomach Neoplasms -- drug therapy
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial Protocol; Journal Article
There are no comments on this title.
Log in to your account to post a comment.